Israeli troops open fire at Palestinians seeking food from distribution hubs in Gaza, over 30 killed
The incidents took place near hubs operated by the Gaza Humanitarian Foundation, added health officials.
In May 2024, the Gaza Humanitarian Foundation launched operations with backing from the US and Israel.
The United States and Israel governments are seeking to replace the traditional UN-led aid distribution system in Gaza, saying that Hamas militants siphon off supplies, which the UN denies.
While the GHF says it has distributed millions of meals to hungry Palestinians, local health officials and witnesses say that hundreds of people have been killed by Israeli army fire as they try to reach the distribution hubs.
The Israeli Army -- not at the sites but secures them from a distance -- has said that it only fires warning shots if crowds get too close to its forces.
On the other hand, Gaza Humanitarian Foundation said there have been no deadly shootings at its sites, though this week. But 20 people were killed at one of its locations, most of them in a stampede.
The GHF accused Hamas agitators of causing a panic, but gave no evidence to back the claim. The army and GHF did not immediately comment on Saturday's violence.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
5 hours ago
- News18
Israeli probe finds Gaza hunger reports inflated, deaths misattributed
Tel Aviv [Israel] August 12 (ANI/TPS): Israel's security establishment said Tuesday that a detailed investigation had exposed 'the lie of the 'starvation campaign,'" accusing Hamas of fabricating and exaggerating claims of famine in the Gaza to the Coordinator of Government Activities in the Territories (COGAT), the inquiry found that Hamas' Ministry of Health 'biased and misleadingly" presented malnutrition data, sometimes attributing deaths of people with severe pre-existing conditions to hunger. 'Hamas is cynically using tragic images and misusing them for the purposes of an awareness campaign," COGAT said, calling the reports 'false" and 'a timed pressure tool" to sway international opinion against is a unit of the Israeli Defense Forces that coordinates civilian issues in Judea, Samaria and investigation highlighted sharp discrepancies between the official numbers reported by Hamas and documented cases identified in media or social media. COGAT noted that until June 2025, Hamas reported 66 deaths from malnutrition during the war. In July alone, that number allegedly jumped to more than 133 — an increase COGAT linked to the run-up to negotiations. However, in contrast to earlier months, Hamas did not publish the names or details of the deceased in July, and Israeli analysis 'reveals only a few cases" matching the cases where identities were confirmed, COGAT said most victims had severe underlying image widely circulated on social media showed four-year-old Abdullah Hani Muhammad Abu Zarqa, whose condition was attributed to hunger. Israeli authorities said a medical examination found he suffered from a hereditary metabolic disorder causing vitamin and mineral deficiencies, calcium loss, and bone thinning — a disease that affected other family members as well. They added that four months before the war, Abdullah had traveled with his mother to eastern Jerusalem's Al-Maqassad Hospital for treatment with Israeli case involved 27-year-old Karem Khaled Mustafa Al-Jamal, reported by Hamas to have died of malnutrition. COGAT said he had muscular dystrophy and partial paralysis since childhood, leading to swallowing difficulties — a chronic condition unrelated to the security review, conducted with medical professionals, concluded there were 'no signs indicating a widespread phenomenon of malnutrition among the population in Gaza." COGAT said Israel would continue 'to improve the humanitarian response in the Gaza Strip, in cooperation with the international community, while rejecting claims of famine."A special report by The Press Service of Israel on Thursday in July found that according to the UN's own numbers, a staggering 85% of the aid entering the Gaza Strip by truck since May 19 has been stolen. The investigation found that a combination of black market profiteers and inflation have made much of the aid in Gaza markets unaffordable for most Palestinians.'There is some hunger in Gaza, and it exists only in places Hamas is pursuing it, not in other areas," Professor Eytan Gilboa an expert in international relations and media at Reichman University in Herzliya, told 1,200 people were killed, and 252 Israelis and foreigners were taken hostage in Hamas's attacks on Israeli communities near the Gaza border on October 7. Of the 50 remaining hostages, around 30 are believed to be dead.(ANI/TPS)
&w=3840&q=100)
Business Standard
8 hours ago
- Business Standard
Citigroup, GS, others buy 15.67% stake in Medi Assist Health for ₹578 cr
Citigroup Global Markets Mauritius, Goldman Sachs, Morgan Stanley are among entities that collectively picked up a 15.67 per cent stake in Medi Assist Healthcare Services for Rs 578 crore through open market transactions on Tuesday. In addition, Kotak Mahindra Mutual Fund (MF), Aditya Birla Sun Life MF, ICICI Prudential MF, Aditya Birla Sun Life Insurance Company, Canadian Crown Corp PSP Investments, and US-based Wasatch Global Investors are the other entities that have cumulatively bought more than 1.1 crore shares or 15.67 per cent stake in Medi Assist Healthcare Services, as per block deal data on the NSE. The shares were purchased at an average price of Rs 522.70 apiece, taking the transaction value to Rs 577.84 crore. Meanwhile, Bessemer India Capital Holdings II Ltd, one of the promoters of Medi Assist Healthcare Services, exited by divesting its entire 15.67 per cent stake in the company. Shares of Bengaluru-based Medi Assist Healthcare Services rose 5.31 per cent to close at Rs 555.95 apiece on the NSE. In September 2024, Bessemer India Capital Holdings II pared a 13.5 per cent stake in Medi Assist Healthcare Services for Rs 580 crore.
News18
9 hours ago
- News18
Cohance Lifesciences announces USD 10 mn investment in US-based arm
New Delhi, Aug 12 (PTI) Cohance Lifesciences on Tuesday announced a strategic investment of USD 10 million (around Rs 87.6 crore) to expand bioconjugation capabilities at its US-based subsidiary, NJ Bio. The investment advances Cohance's global expansion in niche technology-led modalities, enhancing its ability to support innovators from early development through late-phase clinical supply, the company said in a statement. The common good manufacturing practices (cGMP) compliant bioconjugation suite at NJ Bio's Princeton, New Jersey, facility significantly strengthens the company's capabilities to deliver fully integrated Antibody-Drug Conjugate (ADC) solutions, it added. 'The investment … strengthening our footprint in the rapidly growing ADC space. By integrating payload-linker development and bioconjugation capabilities under one roof, NJ Bio will be well-positioned to support accelerated development timelines and help bring life-saving therapies to patients faster," Vivek Sharma, Executive Chairman, Cohance Lifesciences, said. In a separate statement, Cohance announced a Rs 23 crore investment and significant progress on its new oligonucleotide building block manufacturing facility in Hyderabad. 'Together, these investments form part of Cohance's planned capacity expansion program across high-growth modalities, enhancing its ability to serve global innovators from early development to commercial supply," the company said. Cohance Lifesciences, formerly Suven Pharmaceuticals, is an innovator-focused global Contract Research, Development, and Manufacturing Organization (CRDMO), formed through the merger of Cohance Life Sciences into Suven Pharmaceuticals. PTI MSS MR view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
